ondansetron has been researched along with amphetamine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (54.55) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cowen, PJ; Johnson, B; Oldman, D; Silverstone, PH | 1 |
Cowen, PJ; Johnson, B; Silverstone, PH | 1 |
Moser, PC | 1 |
Hietala, J; Koulu, M; Lappalainen, J; Sjöholm, B; Virtanen, R | 1 |
Everitt, BJ; Muir, JL; Robbins, TW | 1 |
Feldon, J; Gray, JA; Joseph, MH; Warburton, EC; Weiner, I | 1 |
De Deurwaerdère, P; Moison, D; Porras, G; Spampinato, U | 1 |
1 review(s) available for ondansetron and amphetamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for ondansetron and amphetamine
Article | Year |
---|---|
Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers.
Topics: Adult; Affect; Amphetamine; Analysis of Variance; Arousal; Blood Pressure; Double-Blind Method; Humans; Hunger; Imidazoles; Male; Mental Processes; Middle Aged; Ondansetron; Pilot Projects; Psychomotor Performance; Reference Values; Serotonin Antagonists | 1992 |
Does ondansetron attenuate amphetamine-induced behaviour in human volunteers?
Topics: Adult; Amphetamine; Behavior; Humans; Hunger; Imidazoles; Male; Middle Aged; Ondansetron; Reference Values; Serotonin Antagonists | 1992 |
8 other study(ies) available for ondansetron and amphetamine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
The effect of 5-HT3 receptor antagonists on the discriminative stimulus effects of amphetamine.
Topics: Amphetamine; Animals; Discrimination Learning; Imidazoles; Indoles; Male; Ondansetron; Quinolizines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Tropanes; Tropisetron | 1992 |
5-HT3 receptor antagonist ondansetron does not alter effects of amphetamine on DA metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Biogenic Monoamines; Brain Chemistry; Dopamine; Homovanillic Acid; Imidazoles; Male; Neurons; Ondansetron; Rats; Rats, Inbred Strains; Serotonin Antagonists | 1990 |
Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron.
Topics: Amphetamine; Animals; Attention; Cerebral Cortex; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Male; Nicotine; Ondansetron; Parasympathetic Nervous System; Physostigmine; Prosencephalon; Rats; Reaction Time | 1995 |
Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antipsychotic Agents; Conditioning, Operant; Dopamine; Electroshock; Emotions; Haloperidol; Male; Ondansetron; Rats; Rats, Sprague-Dawley; Serotonin Antagonists | 1994 |
Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum.
Topics: Amphetamine; Analgesics, Opioid; Animals; Brain Chemistry; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Citalopram; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Electrochemistry; Haloperidol; Male; Microdialysis; Morphine; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT3 Receptor Antagonists; Tropanes | 2003 |